We are live on ! Find out more
EUCRW

Eucrates Biomedical Acquisition Corp. Warrant
EUCRW

Delisted

EUCRW was delisted on the 26th of April, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of EUCRW yet.

EUCRW Hedge Fund Activity: Q2 2023 in Review

0 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Eucrates Biomedical Acquisition Corp. Warrant (EUCRW) for Q2 2023, worth a combined $0 — down 100% from $731K a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of EUCRW and 0 opened new positions — a net loss of 22 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was EcoR1 Capital, exiting entirely with an estimated $676K sold.

  • 0 institutional investors held Eucrates Biomedical Acquisition Corp. Warrant (EUCRW) as of Q2 2023, down from 22 in Q1 2023.
  • Funds reported $0 of Eucrates Biomedical Acquisition Corp. Warrant stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Eucrates Biomedical Acquisition Corp. Warrant positions in Q2 2023 and 22 closed out, a net change of -22 holders.
  • The largest Eucrates Biomedical Acquisition Corp. Warrant seller in Q2 2023 was EcoR1 Capital, an estimated $676K sold.

Based on aggregated 13F filings for Q2 2023.